The last but not least problem is with antibiotics, especially during the acute phase of sepsis, as the management of dosing is very difficult during RRT and is probably better to favor continuous methods than intermittent ones.
Commercial CPOE systems, including Horizon Expert Orders, often use formulary references such as First Databank [ 31] or Lexicon-Multum [ 32] for static dosing advice (e.g., drug-drug interactions or allergy alerts) but not for active dosing assistance or management of the dosing process where tailored doses are suggested based on the patient's clinical profile.
There is, theoretically, a third option, with patients testing themselves with or without self-management of dosing.
VPA is primarily metabolized by the liver; therefore, the management of the dose and blood level should be relatively easy because of its low dialyzability [ 15].
It is apparent from the present study that interindividual pharmacokinetic differences among patients can be compensated by clinical management of the doses of methadone (e.g. dose requirements of UM patients).
Globally from the present study, it is apparent that interindividual pharmacokinetic differences among patients can be compensated by clinical management of the doses of methadone, with little influence, if any, from pharmacogenetics of drug metabolizing enzymes and protein transporters.
RRT must be conducted with the appropriate management of drug dosing, thermal control, volume and electrolyte balance.
These include changes in the metabolism of pharmaceutical agents with age; drug interactions from the co-administration of multiple therapies; cognitive impairments resulting in issues with compliance [ 24] and problems with the management of stress-dosing when required [ 10]; and an increasing prevalence of co-morbid conditions with advancing age [ 24].
We report the herbicide resistance observed in the both herbicide-resistant R and initially susceptible S parental population, the variability of F1 families, the polygenic segregation found in F2 and back-cross (BC) families and discuss the management of low-dose-selected polygenic herbicide resistance.
The management of end-of-dose pain is usually to increase the dose or to shorten the interval of regular analgesic administration to control the baseline pain.
